The manager http://www.meltemok.com/mysupplementsstore-140a.pdf mysupplements.store coupon  After paying down debt from its 2009 takeover of Californianbiotech Genentech for nearly $47 billion, Roche is soon expectedto be back within its target range for a net debt to totalassets ratio of 0-15 percent, so they have room to take on more.